KMTS: Kwo Elizabeth discloses a sale

By AlphaYouPublished Sep 23, 2026Form 4

Stocks in this disclosure

Reported activity

Kwo Elizabeth

Reporting filer

Kwo Elizabeth reported Sale in KESTRA MEDICAL TECHNOLOGIES, LTD.: 4010 units of Common Shares, dated 2026-09-21. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 23, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Shares	Kwo Elizabeth	2026-09-21	S	Sale	4010	24.2563	14,116	2 days	Filed terms security Title: Common Shares transaction Date: 2026-09-21 transaction Form Type: 4 transaction Code: S equity Swap Involved: false id: F1 transaction Shares: 4010 transaction Price Per Share: 24.2563 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 14116 direct Or Indirect Ownership: D

Common Shares

Owner: Kwo Elizabeth
Date: 2026-09-21
Code: S
Action: Sale
Quantity: 4010
Price: 24.2563
Following holdings: 14,116
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Shares
transaction Date: 2026-09-21
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 4010
transaction Price Per Share: 24.2563
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 14116
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Kwo Elizabeth: Director.
F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.2200 to $24.3200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Shares

Kwo Elizabeth

2026-09-21

Sale

4010

24.2563

14,116

2 days

Filed terms

security Title: Common Shares
transaction Date: 2026-09-21
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 4010
transaction Price Per Share: 24.2563
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 14116
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Kwo Elizabeth: Director.

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.2200 to $24.3200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.